[DPHARMA] YoY TTM Result on 30-Sep-2022 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
09-Nov-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Sep-2022 [#3]
Profit Trend
QoQ- -0.89%
YoY- 3.79%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 689,186 690,201 627,817 573,571 554,341 495,341 429,767 8.18%
PBT 71,581 86,632 86,327 69,625 74,528 54,833 45,270 7.93%
Tax -10,276 -17,965 -20,167 -15,175 -16,919 -9,793 -5,416 11.25%
NP 61,305 68,667 66,160 54,450 57,609 45,040 39,854 7.43%
-
NP to SH 61,305 68,667 66,160 54,450 57,609 45,277 40,548 7.12%
-
Tax Rate 14.36% 20.74% 23.36% 21.80% 22.70% 17.86% 11.96% -
Total Cost 627,881 621,534 561,657 519,121 496,732 450,301 389,913 8.26%
-
Net Worth 673,359 647,522 612,147 584,565 505,919 501,487 474,230 6.01%
Dividend
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Div 21,929 21,685 45,892 37,536 33,094 20,937 7,085 20.70%
Div Payout % 35.77% 31.58% 69.37% 68.94% 57.45% 46.24% 17.47% -
Equity
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Net Worth 673,359 647,522 612,147 584,565 505,919 501,487 474,230 6.01%
NOSH 961,942 952,239 941,765 706,026 680,106 661,881 278,959 22.90%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin 8.90% 9.95% 10.54% 9.49% 10.39% 9.09% 9.27% -
ROE 9.10% 10.60% 10.81% 9.31% 11.39% 9.03% 8.55% -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
RPS 71.65 72.48 66.66 82.42 82.18 75.07 154.06 -11.97%
EPS 6.37 7.21 7.03 7.82 8.54 6.86 14.54 -12.84%
DPS 2.30 2.28 4.87 5.50 5.00 3.17 2.54 -1.63%
NAPS 0.70 0.68 0.65 0.84 0.75 0.76 1.70 -13.74%
Adjusted Per Share Value based on latest NOSH - 952,239
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
RPS 71.65 71.75 65.27 59.63 57.63 51.49 44.68 8.18%
EPS 6.37 7.14 6.88 5.66 5.99 4.71 4.22 7.10%
DPS 2.30 2.25 4.77 3.90 3.44 2.18 0.74 20.79%
NAPS 0.70 0.6731 0.6364 0.6077 0.5259 0.5213 0.493 6.01%
Price Multiplier on Financial Quarter End Date
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Date 29/09/23 30/09/22 30/09/21 30/09/20 30/09/19 28/09/18 29/09/17 -
Price 1.20 1.30 1.81 3.16 1.40 1.23 2.20 -
P/RPS 1.67 1.79 2.72 3.83 1.70 1.64 1.43 2.61%
P/EPS 18.83 18.03 25.76 40.39 16.39 17.93 15.14 3.70%
EY 5.31 5.55 3.88 2.48 6.10 5.58 6.61 -3.58%
DY 1.92 1.75 2.69 1.74 3.57 2.58 1.15 8.91%
P/NAPS 1.71 1.91 2.78 3.76 1.87 1.62 1.29 4.80%
Price Multiplier on Announcement Date
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Date 08/11/23 09/11/22 18/11/21 12/11/20 29/11/19 28/11/18 17/11/17 -
Price 1.22 1.39 1.62 4.04 1.39 1.07 2.20 -
P/RPS 1.70 1.92 2.43 4.90 1.69 1.43 1.43 2.92%
P/EPS 19.14 19.28 23.06 51.63 16.28 15.59 15.14 3.98%
EY 5.22 5.19 4.34 1.94 6.14 6.41 6.61 -3.85%
DY 1.89 1.64 3.01 1.36 3.60 2.97 1.15 8.62%
P/NAPS 1.74 2.04 2.49 4.81 1.85 1.41 1.29 5.11%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment